Vanessa Agostini

ORCID: 0009-0007-9662-0245
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Trauma and Emergency Care Studies
  • Blood transfusion and management
  • Science and Education Research
  • Education Pedagogy and Practices
  • Education and Digital Technologies
  • Abdominal Trauma and Injuries
  • Blood donation and transfusion practices
  • Cancer therapeutics and mechanisms
  • Lung Cancer Research Studies
  • Lung Cancer Treatments and Mutations
  • Maternal and fetal healthcare
  • Lymphoma Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • Evasion and Academic Success Factors
  • Hemophilia Treatment and Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Platelet Disorders and Treatments
  • Enhanced Recovery After Surgery
  • Blood groups and transfusion
  • Chronic Lymphocytic Leukemia Research
  • Complement system in diseases
  • Environmental Sustainability and Education
  • Hemoglobinopathies and Related Disorders

Ospedale Policlinico San Martino
2020-2024

Jisc
2024

Istituto Nazionale di Fisica Nucleare, Sezione di Genova
2023

Universidade do Oeste de Santa Catarina
2014-2021

University of the West
2021

Azienda Unità Sanitaria Locale Della Romagna
2019-2020

Ospedale “M. Bufalini” di Cesena
2007-2019

Azienda-Unita' Sanitaria Locale Di Cesena
2015

Ospedale Infermi di Rimini
2004-2007

City Hospital
2004

Hemorrhage is the principal cause of death in first few hours following severe injury. Coagulopathy a frequent complication critical bleeding. A network Italian trauma centers recently developed protocol to prevent and treat trauma-induced coagulopathy. pre-post cohort multicenter study was conducted assess impact early coagulation support (ECS) on blood products consumption, mortality treatment costs.We prospectively collected data from all severely injured patients (Injury Severity Score...

10.1186/s13054-015-0817-9 article EN cc-by Critical Care 2015-02-25

Beta thalassemia (β-thalassemia) is part of a group inherited hemoglobinopathies caused by mutation in the beta globin gene, leading to minimal functional hemoglobin and resulting damaged red blood cells anemia. β-Thalassemia most common Mediterranean region, South-East Asia, Indian subcontinent, Middle East. Many these regions include low- middle-income countries where there are significant unmet needs adequate care management thalassemia. Patients with transfusion-dependent β-thalassemia,...

10.3389/frhem.2023.1187681 article EN cc-by Frontiers in Hematology 2023-06-20

Summary We evaluated the additional benefit of Technetium 99 ‐sestamibi (99mTc‐MIBI) scanning in comparison with standard X‐ray techniques for multiple myeloma patients either at diagnosis or during follow‐up. Between February 2001 and January 2005, 397 whole body scans were acquired. On 229 performed diagnosis, 146 (64%) positive 81 cases have discordant results. The sensitivity 99mTc‐MIBI 77% 45% respectively. As a result 99mTc‐MIBI, 40% asymptomatic up‐staged. positivity correlated...

10.1111/j.1365-2141.2006.06489.x article EN British Journal of Haematology 2007-01-18

Postpartum hemorrhage (PPH) is one of the most frequent causes mortality and morbidity in obstetric population globally, causing about a quarter maternal deaths yearly, leading cause death worldwide. The management PPH remains topic great debate, even view new diagnostic therapeutic possibilities recent years, for which, however, body evidence available thus far still scarce, as standard values are lacking. protocol hereby presented was developed after literature review during several...

10.7417/t.2017.2026 article EN PubMed 2017-10-19

Patient blood management (PBM) is defined as the timely application of evidence-based medical and surgical concepts designed to maintain a patient’s hemoglobin concentration, optimize hemostasis, minimize loss in an effort improve outcomes. PBM able reduce mortality up 68%, reoperation 43%, readmission composite morbidity 41%, infection rate 80%, average length stay by 16%–33%, transfusion from 10% 95%, costs 84% after major surgery. It should be noticed, however, that process implementation...

10.1097/ia9.0000000000000041 article EN Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons 2024-01-25

Since 2012, in line with the World Health Organization (WHO) resolution WHA63.12 of 05/21/2010, Italian National Blood Center has been promoting patient blood management (PBM). In order to verify level PBM implementation nationwide, we submitted a survey all healthcare providers.

10.2450/bloodtransfus.724 article EN PubMed 2024-03-28

Adherence to optimal practices in the preparation and issuance of pediatric blood components can significantly influence patient care outcomes. This study aims examine banking procedures across prominent Italian children's hospitals, with goal identifying both consistent potentially divergent standards within this field.

10.2450/bloodtransfus.838 article EN PubMed 2024-11-29

In recent years, a strong focus has been put on the need to assure early coagulation support in order prevent and treat coagulopathy patients with severe trauma, improve survival.Aggressive plasma administration high plasma/ red blood cells ratio is increasingly used worldwide.However, transfusion associated increased risks of multiple organ dysfunction syndrome (MODS), adult respiratory distress (ARDS) infection, which may prolong hospital stay for artificial ventilation.Moreover, majority...

10.7243/2049-9752-2-22 article EN cc-by journal of Anesthesiology and Clinical Science 2013-01-01

Chronic Lymphocytic Leukemia (CLL) is characterized by the accumulation of monoclonal CD5+ B cells with low surface immunoglobulins (IG). About 40% CLL clones utilize quasi-identical cell receptors, defined as stereotyped BCR. CLL-like stereotyped-IG rearrangements are present in normal a part public IG repertoire. In this study, we collected details on representation and features IGH repertoire B-cell subpopulations purified from peripheral blood nine healthy donors. The were also...

10.3389/fonc.2022.894419 article EN cc-by Frontiers in Oncology 2022-06-23

Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening microangiopathy caused by severe ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin motifs 13) deficiency, recurring in 30–50% of patients. The common human leukocyte antigen (HLA) variant rs6903608 was found to be associated prevalent iTTP, but whether this disease relapse unknown. To estimate the impact on iTTP onset relapse, we performed case-control cohort study 161 Italian patients...

10.3390/jcm9103379 article EN Journal of Clinical Medicine 2020-10-21

Natural Killer cells (NKs) represent the innate counterpart of TCRαβ lymphocytes and are characterized by a high anti-tumor an anti-viral cytotoxic activity. Recently, it has been demonstrated that NKs can express PD-1 as additional inhibitory receptor. Specifically, was identified on subpopulation terminally differentiated from healthy adults with previous HCMV infection. So far is unknown whether appears during NK-cell development this process directly or indirectly related to In study, we...

10.3389/fimmu.2023.1183215 article EN cc-by Frontiers in Immunology 2023-06-22

Background Cisplatin-containing regimens represent the gold standard in treatment of advanced non-small cell lung cancer, but carboplatin is often preferred for its better toxic profile when palliation aim treatment. The synergistic effect and tolerability carboplatin-gemcitabine combination are well known. In this phase II trial, we evaluated activity safety a schedule with gemcitabine, defined our previous I trial. Methods Thirty-seven patients measurable stage IV cancer were treated...

10.1177/030089160409000113 article EN Tumori Journal 2004-01-01

Worldwide iron anemia is a common disorder with significant economic burden on health-care systems. Red blood cell transfusion the mainstay to correct in surgical settings, but it also an overused procedure and recent data support its possible role worsening patient outcomes. Patient Blood Management (PBM) multidisciplinary approach optimize hemostasis, manage anemia, minimize iatrogenic loss, improve tolerance anemia. The present paper aims provide "bundles" approach, based several...

10.1016/j.transci.2020.102874 article EN cc-by-nc-nd Transfusion and Apheresis Science 2020-07-15

Immune checkpoint inhibitors (CI) have demonstrated clinical activity in Hodgkin Lymphoma (HL) patients relapsing after autologous stem cell transplantation (ASCT), although only 20% complete response (CR) rate was observed. The efficacy of CI is strictly related to the host immune competence, which impaired heavily pre-treated HL patients. Here, we aimed enhance early post-ASCT (nivolumab) administration with infusion lymphocytes (ALI). Twelve relapse/refractory (R/R) (median age 28.5...

10.3389/fimmu.2021.753890 article EN cc-by Frontiers in Immunology 2021-11-05
Coming Soon ...